Related Experiment Video
Updated: Jul 16, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T
Davorka Messmer1, Ikusuke Hatsukari, Naoko Hitosugi
1Laboratory of Experimental Immunology, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, USA. dmessmer@ucsd.edu
Abstract:
We evaluated the effect of morphine on human dendritic cells (DCs). Interestingly, immature DCs were found to express all 3 (mu, kappa, delta) opioid receptors on the cell surface. Chronic morphine treatment (10(-8) to 10(-12) M) during the development of DCs from monocytes augmented LPS-induced upregulation of HLA-DR, CD86, CD80, and CD83 and increased the T cell stimulatory capacity of DCs, which could be inhibited by naloxone, an opioid receptor antagonist. The change in surface phenotype was paralleled by a p38 MAPK-dependent decrease in IL-10 and increase in IL-12 secretion. Our data indicate that morphine exerts an immunostimulatory effect by modulating LPS-induced DC maturation.
Insights
Morphine enhances the immune response by modulating dendritic cell (DC) maturation. This opioid receptor activation boosts T cell stimulation, indicating an immunostimulatory effect.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Dendritic cells (DCs) are key immune regulators.
- Opioid receptors (mu, kappa, delta) are expressed on immune cells.
- Morphine's immunomodulatory effects are not fully understood.
Purpose of the Study:
- To investigate the effect of morphine on human dendritic cell (DC) development and function.
- To determine if morphine influences DC maturation and T cell stimulatory capacity.
Main Methods:
- Human monocytes were differentiated into DCs in the presence of varying concentrations of morphine.
- LPS-induced maturation markers (HLA-DR, CD86, CD80, CD83) and cytokine secretion (IL-10, IL-12) were analyzed.
- T cell stimulatory capacity was assessed, and the role of opioid receptors was examined using naloxone.
Main Results:
- Immature DCs expressed mu, kappa, and delta opioid receptors.
- Chronic morphine treatment augmented LPS-induced upregulation of DC maturation markers.
- Morphine increased DC T cell stimulatory capacity, decreased IL-10, and increased IL-12 secretion in a p38 MAPK-dependent manner.
- Naloxone reversed the effects of morphine.
Conclusions:
- Morphine exerts an immunostimulatory effect on human DCs.
- Morphine modulates LPS-induced DC maturation and enhances T cell stimulatory capacity.
- These effects are mediated through opioid receptors and involve p38 MAPK signaling.
Related Concept Videos
Opioid Receptors: Overview
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Differentiation of Common Myeloid Progenitor Cells

